Jan 14, 2014 by Max MacalusoWhy Biotech Boomer Intercept Pharmaceuticals, Inc. Tumbled AgainWhy did Intercept shares tumble today?
Jan 14, 2014 by Max MacalusoUp 140%: Why Chelsea Therapeutics International Ltd. Is Soaring After-HoursWhy is Chelsea Therapeutics set to soar tomorrow?
Jan 13, 2014 by Max MacalusoThe 3 Worst-Performing Big Pharma Stocks of 2013: LLY, NVO, SNYWhich big pharma stocks stumbled last year?
Jan 10, 2014 by Max Macaluso and Dave WilliamsonUp 61%: Why Intercept Pharmaceuticals Inc. Popped Again TodayWhy Intercept Pharmaceuticals popped again today.
Jan 10, 2014 by Max Macaluso and Dave WilliamsonDown 29%: Why Chelsea Therapeutics International Ltd. Shares Crashed TodayWhy did Chelsea Therapeutics shares tumble today?
Jan 9, 2014 by Max MacalusoRed Light, Green Light: 2 Things to Know Before Buying Teva Pharmaceutical Industries Ltd (ADR) StockWhat do investors need to know before investing in drugmaker Teva?
Jan 7, 2014 by Max MacalusoRoche's Genentech and the Culture of InnovationWhy Roche continues to impress investors and develop game-changing drugs.
Jan 6, 2014 by Max MacalusoThe 5 Best-Performing Big Pharma Stocks of 2013: BMY, ABBV, RHHBY, JNJ, AZNThe pharmaceutical sector had a stellar 2013, but which stocks were the best?
Jan 2, 2014 by Max MacalusoWhy Big Pharma Companies Need to CollaborateThe pharmaceutical industry has historically been very secretive, but collaborating is a key to innovation according to Bernard Munos.
Jan 2, 2014 by Max MacalusoAre Pharma Companies Too Big to Innovate?Does size matter when it comes to innovation in the pharmaceutical industry?
Dec 31, 2013 by Max Macaluso and Rex MooreHow Mobile Technology Is Changing Medicine As We Know ItmHealth, or mobile health, could be one of the biggest buzzwords of 2014. But what is this fledgling field all about, and why are tech companies like Qualcomm and Verizon becoming major players in the health-care space?
Dec 18, 2013 by Max MacalusoGlaxoSmithKline: The World's Biggest Biotech Startup?GlaxoSmithKline's discovery performance units make the company resemble a collection of biotech start-ups rather than a big pharma giant.
Dec 18, 2013 by Max MacalusoSanofi: The Most Successful Comeback in Big Pharma History?How did Sanofi CEO Chris Viehbacher help turn the pharmaceutical giant around?
Dec 18, 2013 by Max MacalusoHow Gleevec Changed the Game for NovartisNovartis' first rule of innovation -- forget the forecasts, focus on the science.
Dec 17, 2013 by Max MacalusoIs Culture the Solution to Big Pharma's Innovation Problem?Innovation isn't a function of a big pocketbook or complex processes. Instead, companies should focus on culture to foster an entrepreneurial spirit.
Dec 15, 2013 by Max Macaluso and Michael Olsen, CFAObamacare's Latest Enrollment Numbers: Good News or Bad News?Are the latest Obamacare enrollment numbers too low, is the significant uptick in sign-ups encouraging, or is it simply too soon for consumers and investors to be concerned?
Dec 15, 2013 by Max MacalusoWhat Will the Fitbit Look Like in 5 Years?Consumer demand for activity trackers is rising, and companies in this space continue to innovate. However, looking ahead over the next five years, what can companies like Fitbit come up with to help consumers monitor their health? What will Fitbit's devices be able to in the future?
Dec 15, 2013 by Max Macaluso and Rex MooreCan Mobile Gaming Help Save Lives?Video games have historically been associated with causing poor health, but can pharmaceutical companies turn mobile games into effective educational tools that can help patients manage chronic diseases?
Dec 15, 2013 by Max Macaluso and Rex MooreWill Wearable Technology Be the Next Big Innovation in Health Care?How wearable technology is already changing the way consumers think about their health.
Dec 13, 2013 by Max MacalusoMerck Stock: 3 Key Things to Watch NowWhat are three key topics that Merck investors need to focus on right now?
